Gastro Health

What Are Gastro Health? 

Gastrointestinal conditions encompass a broad spectrum — from peptic ulcer disease and GERD to inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and hepatic conditions. Together they represent one of the highest burdens on global healthcare systems. AmozonPill stocks 97 generic gastro health medications covering acid suppression, H. pylori eradication, anti-inflammatory bowel agents, antispasmodics, and hepatic therapies — sourced from FDA-inspected, WHO-GMP manufacturers at up to 95% below brand-name prices. 

Drug Classes Available 

• Proton Pump Inhibitors (PPIs): Omeprazole, Esomeprazole, Pantoprazole, Rabeprazole — suppress gastric acid for GERD, peptic ulcer, and H. pylori eradication. (See also Acid Reducers category for full range.) 

• H. pylori Eradication: Clarithromycin + Amoxicillin + PPI (Triple Therapy), Bismuth Quadruple Therapy — 7–14 day regimens achieving 80–90% H. pylori eradication rates. Essential for preventing peptic ulcer recurrence. 

• IBD Agents: Mesalazine (5-ASA), Sulfasalazine — first-line anti-inflammatory agents for mild-to-moderate ulcerative colitis and Crohn’s disease. Reduce mucosal inflammation and maintain remission. 

• Antispasmodics & IBS Agents: Mebeverine, Hyoscine Butylbromide (Buscopan generic), Dicyclomine — reduce bowel spasm in IBS. Fast-acting relief for abdominal cramping and bloating. 

• Liver & Bile Agents: Ursodeoxycholic Acid (UDCA), Silymarin — UDCA dissolves cholesterol gallstones and is first-line for primary biliary cholangitis. Silymarin (milk thistle extract) is hepatoprotective in alcoholic liver disease. 

Why Buy Generic? 

• Generic Mesalazine from $22 vs $150+ for Asacol brand 
• Generic Mebeverine from $14 vs $45+ for Colofac brand 
• Generic UDCA from $24 vs $90+ for Ursodiol brand 
• FDA-inspected, WHO-GMP-certified manufacturers 
• Free shipping on orders over $199 

How to Choose the Right Product 

For GERD or peptic ulcer: a PPI (Omeprazole 20–40 mg before breakfast) is first-line. For confirmed H. pylori: a PPI-based triple or quadruple eradication regimen for 7–14 days. For ulcerative colitis or Crohn’s disease: Mesalazine granules or tablets — dose and formulation depend on disease extent and activity under gastroenterologist guidance. For IBS with spasm: Mebeverine 135 mg three times daily before meals. For primary biliary cholangitis: UDCA 13–15 mg/kg/day in divided doses. 

Frequently Asked Questions

What is H. pylori and how is it treated? 

Helicobacter pylori is a bacterium that colonises the stomach lining and is the leading cause of peptic ulcer disease and gastric cancer. Standard treatment is triple therapy: PPI + Clarithromycin + Amoxicillin for 7–14 days, achieving 80–90% eradication. Eradication confirmation by breath test or stool antigen test 4 weeks after completion is recommended. 

What is the difference between Mesalazine and Sulfasalazine for IBD? 

Mesalazine (5-ASA) is the active component of Sulfasalazine without the sulphapyridine carrier, resulting in significantly fewer side effects. Mesalazine is preferred for most patients with ulcerative colitis. Sulfasalazine retains use in IBD with coexisting arthritis due to its additional immunomodulatory effects.

How does Mebeverine work for IBS? 

Mebeverine is a direct smooth muscle relaxant that reduces intestinal spasm without anticholinergic side effects. It is taken 20 minutes before meals and provides fast relief of abdominal cramping and altered bowel habit in IBS. 

Can PPIs be taken long-term? 

PPIs are safe for long-term use under physician guidance. Long-term concerns include slightly increased risk of hypomagnesaemia, B12 deficiency, C. difficile infection, and bone fractures at high doses. Regular review of the continuing need for PPI therapy is recommended. 

What is Ursodeoxycholic Acid used for? 

UDCA is a naturally occurring bile acid that reduces cholesterol saturation in bile, dissolving cholesterol gallstones (in selected patients), and is the only approved pharmacological treatment for primary biliary cholangitis (PBC). It also has hepatoprotective effects in non-alcoholic fatty liver disease. 

What is the difference between IBD and IBS? 

IBD (Crohn’s disease, ulcerative colitis) is a chronic inflammatory disease of the bowel confirmed by endoscopy and histology — it causes structural bowel damage and requires immunosuppressive therapy. IBS (irritable bowel syndrome) is a functional disorder without structural change — it is managed with diet, antispasmodics, and symptom-targeted agents.